NASDAQ:CERO CERo Therapeutics (CERO) Stock Price, News & Analysis → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free CERO Stock Alerts $1.10 -0.03 (-2.65%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$1.08▼$1.1750-Day Range$1.10▼$3.0752-Week Range$1.08▼$12.80Volume61,737 shsAverage Volume103,850 shsMarket Capitalization$16.19 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media Get CERo Therapeutics alerts: Email Address Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. About CERo Therapeutics Stock (NASDAQ:CERO)CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.Read More CERO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CERO Stock News HeadlinesMay 18 at 4:08 AM | americanbankingnews.comCERo Therapeutics (NASDAQ:CERO) Trading Down 2.7%May 15, 2024 | finanznachrichten.deCERo Therapeutics Holdings, Inc.: CERo Therapeutics, Inc. Provides Corporate Update for ShareholdersMay 15, 2024 | globenewswire.comCERo Therapeutics, Inc. Provides Corporate Update for ShareholdersMay 9, 2024 | seekingalpha.comCERO CERo Therapeutics Holdings, Inc.April 30, 2024 | finance.yahoo.comCERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing AttributesMarch 30, 2024 | msn.comCompare with Bloomberg Emerging Markets Large & Mid Cap Total Return Index NOK (EMTK)March 21, 2024 | wsj.comCERo Therapeutics Holdings Inc.March 17, 2024 | morningstar.comCERo Therapeutics Holdings Inc CEROMarch 11, 2024 | finance.yahoo.comCERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML PatientsSee More Headlines Receive CERO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CERo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:CERO Previous SymbolNASDAQ:CERO CUSIPN/A CIK1870404 Webwww.cero.bio Phone215-731-9450FaxN/AEmployees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares14,720,000Free Float12,398,000Market Cap$16.19 million OptionableN/A Beta-0.08 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Daniel Mark Corey M.D. (Age 45)Founder, CTO & Director Comp: $372.69kMr. Brian G. Atwood (Age 71)President, CEO & Chairman Mr. Charles Ross Carter (Age 56)CFO, Treasurer & Corporate Secretary Dr. Robert Sikorski M.D. (Age 61)Ph.D., Consultant Key CompetitorsPsyence BiomedicalNASDAQ:PBMNewGenIvf GroupNASDAQ:NIVFTraws PharmaNASDAQ:TRAWTalis BiomedicalNASDAQ:TLISAytu BioPharmaNASDAQ:AYTUView All Competitors CERO Stock Analysis - Frequently Asked Questions How have CERO shares performed in 2024? CERo Therapeutics' stock was trading at $4.78 on January 1st, 2024. Since then, CERO shares have decreased by 77.0% and is now trading at $1.10. View the best growth stocks for 2024 here. How do I buy shares of CERo Therapeutics? Shares of CERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CERO) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CERo Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.